top of page

Nkarta CEO Paul Hastings on NK based cell therapies for autoimmune conditions

He describes why Nkarta believes NK cells are uniquely suited for the job.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page